The Partnership for Structural Biology, based at EMBL's Grenoble site, provides common technical platforms for state-of-the-art structural biology projects. Partners coordinate scientific activities and drive the development of new instruments and methods.
Research groups across Australia are linked through the EMBL partnership model. The scientific programme builds on EMBL’s activities in systems biology and capitalises on the strengths of Australian life and health sciences.
Researchers in this partnership investigate how human tissues and organs develop and are organised, advancing our understanding of a wide range of diseases, including heart degeneration, Alzheimer’s, diabetes and tumours.
HCEMM is the Hungarian Centre of Excellence for Molecular Medicine. This partnership focusses on cancer, cardiovascular and inflammatory diseases especially affecting older generations, thereby providing a bridge from fundamental to translational research.
BRAINCITY, the Polish Centre of Excellence for Neural Plasticity and Brain Disorders, is an independent research unit embedded in the Nencki Institute. EMBL provides assistance and expertise in neuroscience.
The Nordic EMBL Partnership is a major strategic player in Europe’s molecular understanding of disease mechanisms, thanks to its complementary research expertise, outstanding research infrastructures and industry collaborations.
Using molecular techniques, the Sars Centre aims to use marine animals as model systems to study development, most often in an evolutionary context. The partnership with EMBL facilitates scientific exchange and supports areas of common interest of the two institutes.
EMBL and VU LSC, recognising the scientific and technological potential of uniting their complementary strengths in the field of targeted genome modification, decided to intensify existing links and build further institutional synergies by creating the Partnership for Genome Editing Technologies.